1Takahashi K,Oharaseki T,Naoe S,et al.Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease[J].Pediatr Int.,2005,47 (3):305-310.
2Singh-Grewal D,Wong M,Isaacs D.Diagnosis,treatment and outcome of Kawasaki disease in an Australian tertiary setting:a review of three years experience[J].J Paediatr Child Health,2005,41 (10):495-499.
3Kawasaki T.Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children (Japanese)[J].Japan J Allergy,1967,16:178-122.
4Du ZD,Zhang T,Liang L,et al.Epidemiologic picture of Kawasaki disease in Beijing from 1995 through 1999[J].Pediatr Infect Dis J,2002,21 (2):103-107.
5Falcini F,Cimaz R,Calabri GB,et al.Kawasaki disease in northem Italy:a multicenter retrospective study of 250 patients.Clin Exp Rheumatol[J].2002 May-Jun,20(3):421-426.
6Zhang T,Yanagawa H,Oki I,et al.Factors related to cardiac sequelae of Kawasaki disease[J].Eur J Pediatr,1999,158:694-697.
7Salice P,Pietrogrande MC,Barbier P,et al.Cardiovascular abnormalities in Kawasaki disease:an Italian prospective study (Italian)[J].Cardiologia,1998,43 (12):1367-1374.
8Laupland KB,Dele DH (1999).Epidemiology,etiology,and management of Kawasaki disease:state of the art[J].Pediatr Cardiol,20:177-183.
9Koyanagi H,Nakamura Y,Yanagawa H.Lower level of serum potassium and higher level of C-reactive protein as an independent risk factor for giant aneurysms in Kawasaki disease[J].Acta Paediatr,1998,87:32-36.
10Mori M,Imagawa T,Yasui K,et al.Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease[J].J Pediatr,2000,137(2):177-180.
